摘要
目的:应用化学交换敏感自旋锁(CESL)磁共振成像技术,研究阿尔茨海默病(AD)模型小鼠脑Aβ蛋白的可交换质子信号。方法:选用8只未转基因小鼠(5只幼龄,3只)和12只TG-APPswe/PSdE 9小鼠(5只幼龄,7只)。ω1=25 Hz,TSL=3.0s,ω1=5 0Hz,TSL=15 0ms,在Ω=7.0ppm的偏移频率不均匀的情况下,在9.4-T动物MRI系统中获得CESLZ-谱。在Z谱分析中,感兴趣区(ROIS)被绘制在两个半球的皮层、海马和丘脑。由Z谱得到了磁化强度传递比不对称(MTRasym)曲线。用Mann-Whitney试验比较TG和非TG小鼠在每一偏移频率和每一ROI上的MTRasym值。结果:饱和功率为25 Hz时,全Z谱的水饱和度宽度较窄,而在500 Hz饱和功率下,水饱和度宽度相对较宽。在25 Hz CESL饱和功率下,大多数MTRasym值在3.5、3.0、2.0和0.9ppm偏移频率下为负值,仅在3.5ppm偏置时,对照组与TG组间MTRasym值有显着性差异(p=0.0487)。MTRasym值分别为-6%~-7%(3.5和3.0 ppm),而2.0和0.9ppm的MTRasym值均小于-2%。在500 Hz CESL饱和功率下,所有MTRasym值在3.5-、3.0-、2.0-和0.9-ppm偏移频率上均为正,MTRasym值在所有ROIS和所有偏移频率上,对照组与TG组之间无显着性差异。然而,在3.5ppm时,对照组与TG组在右侧皮质有显著差异(p=0.0578)。MTRasym值3.5、3.0和2.0ppm时为6%~9%,0.9ppm时MTRasym值小于2%。结论:在体内AD模型实验中,MTRasym值随饱和功率的增加而增加。MTRasym值除左侧丘脑区3.5ppm偏移外,差异无显着性(P>0.05)。CESL技术应进一步发展,使其在神经退行性疾病患者的大脑中得到应用。
关键词: 磁共振成像,可交换质子信号,淀粉样β(Aβ)蛋白,阿尔茨海默病,淀粉样斑块。
Current Alzheimer Research
Title:Mapping Exchangeable Protons to Monitor Protein Alterations in the Brain of an Alzheimer’s Disease Mouse Model by Using MRI
Volume: 15 Issue: 14
关键词: 磁共振成像,可交换质子信号,淀粉样β(Aβ)蛋白,阿尔茨海默病,淀粉样斑块。
摘要: Objective: The study aimed to investigate exchangeable proton signals of Aβ proteins of the brains of Alzheimer’s disease (AD) model mice by using a chemical exchange-sensitive spin-lock (CESL) MR imaging technique.
Method: Eight non-transgenic (Tg) mice (5 young and 3 old) and twelve Tg-APPswe/PSdE9 mice (5 young and 7 old) were used in this study. CESL Z-spectra were obtained by using two saturation powers, which were ω1 = 25 Hz with TSL = 3.0 s and ω1 = 500 Hz with TSL = 150 ms, at 71 offsets with uneven intervals between the offset frequencies at Ω = ±7.0 ppm at a 9.4-T animal MRI system. For Zspectrum analyses, regions of interest (ROIs) were drawn in the cortex, hippocampus, and thalamus of both hemispheres. Magnetization transfer ratio asymmetry (MTRasym) curves were obtained from the Zspectra. The Mann-Whitney test was used to compare the MTRasym values between the Tg and non-Tg mice for each offset frequency and for each ROI.
Results: The water saturation width of the full Z-spectrum was narrow with the 25-Hz saturation power, but relatively broad with the 500-Hz saturation power. With the 25-Hz CESL saturation power, most of the MTRasym values were negative for 3.5-, 3.0-, 2.0-, and 0.9-ppm offset frequencies and the MTRasym values were significantly different between the control and Tg groups only in the left thalamus region at 3.5 ppm offset (p=0.0487). The MTRasym values were -6% to -7% for both 3.5 and 3.0 ppm, but less than -2% for both 2.0 and 0.9 ppm. With 500-Hz CESL saturation power, all the MTRasym values were positive for the 3.5-, 3.0-, 2.0-, and 0.9-ppm offset frequencies and the MTRasym values were not significantly different between the control and Tg groups at all ROIs and at all offset frequencies. However, a trend towards a significant difference was observed between the control and Tg groups in the right cortex at 3.5 ppm (p=0.0578). The MTRasym values were 6% to 9% for 3.5, 3.0, and 2.0 ppm, but less than 2% for 0.9 ppm.
Conclusion: In an in-vivo AD model experiment, MTRasym values increased with the high saturation power than with the low saturation power. The MTRasym values were not significantly different, except in the left thalamus region at 3.5 ppm offset. The CESL technique should be further developed to enable its application in the brain of patients with neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Mapping Exchangeable Protons to Monitor Protein Alterations in the Brain of an Alzheimer’s Disease Mouse Model by Using MRI, Current Alzheimer Research 2018; 15 (14) . https://dx.doi.org/10.2174/1567205015666180911143518
DOI https://dx.doi.org/10.2174/1567205015666180911143518 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Plombage: A Forgotten Surgical Treatment for Pulmonary Tuberculosis
Current Respiratory Medicine Reviews Chemical Composition and Biological Effects of Essential Oils from Some Aromatic and Medicinal Plants
The Natural Products Journal Signs and Related Mechanisms of Ethanol Hepatotoxicity
Current Drug Abuse Reviews Epigenetics in Alzheimers Disease: a Focus on DNA Modifications
Current Pharmaceutical Design Menopausal Transition and Chronic Diseases
Current Women`s Health Reviews Anderson-Fabry Disease in Children
Current Pharmaceutical Design MicroRNA Expression Analysis of Adult-Onset Drosophila Alzheimer`s Disease Model
Current Alzheimer Research Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults
Current Vascular Pharmacology A Brief Overview of Tyrosine Hydroxylase and α-Synuclein in the Parkinsonian Brain
CNS & Neurological Disorders - Drug Targets Screening Neuroprotective Agents Through 4-hydroxynonenal, Ethanol, High Glucose, Homocysteine, Okadaic Acid, Rotenone, and Oxygen-Glucose Deprivation Induced PC12 Injury Models: A Review
Current Psychopharmacology The Role of Cannabinoids in Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
Current Drug Targets Brain: The Potential Diagnostic and Therapeutic Target for Glaucoma
CNS & Neurological Disorders - Drug Targets Conference Report: 8<sup>th</sup> Clinical Trials on Alzheimer Disease (CTAD), Barcelona, Spain November 5-7, 2015
CNS & Neurological Disorders - Drug Targets Recent Patents on Epilepsy Genetics
Recent Patents on DNA & Gene Sequences Pathways of Acetylcholine Synthesis, Transport and Release as Targets for Treatment of Adult-Onset Cognitive Dysfunction
Current Medicinal Chemistry Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
Current Neuropharmacology The Effectiveness of Treatments for Cocaine Dependence in Schizophrenic Patients: A Systematic Review
Current Neuropharmacology Integrated System Pharmacology and <i>In Silico</i> Analysis Elucidating Neuropharmacological Actions of <i>Withania somnifera</i> in the Treatment of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets The Association of MME microRNA Binding Site Polymorphism with the Risk of Late Onset Alzheimer’s Disease in Northern Han Chinese
Current Neurovascular Research Mean Platelet Volume: A Link Between Thrombosis and Inflammation?
Current Pharmaceutical Design